|

Bone marrow mesenchymal stem cells (low dose) Clinical Trials

1 actively recruiting trial

Also known as: CG-BM1

Pipeline

Phase 1/2: 1

Top Sponsors

  • Sun Yat-sen University1

Indications

  • Acute on Chronic Liver Failure1
  • Liver Disease1

Other1 trial

Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.